Using ultrasound-guided erector spinae plane block to manage pain and improve sleep in infants after lung surgery
Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Pain and Sleep Quality of Infants With Congenital Pulmonary Cystic Disease After Thoracoscopic Surgery
This study is testing if a special pain relief method can help babies feel less pain and sleep better after lung surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 1 Month to 12 Months |
| Sex | All |
| Sponsor | Xibei Hospital Academic / other |
| Locations | 1 site (Xi'an, Shanxi) |
| Trial ID | NCT06498583 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the erector spinae plane block (ESPB) in providing postoperative pain relief and enhancing sleep quality in infants undergoing thoracoscopic surgery for congenital pulmonary cystic disease. The research addresses the challenges of managing pain in infants, who cannot communicate their discomfort effectively. By utilizing ESPB, which has fewer complications compared to traditional methods like thoracic epidural block, the study aims to improve recovery outcomes and reduce the risk of pulmonary complications associated with inadequate pain management.
Who should consider this trial
Good fit: Ideal candidates for this study are infants aged 1 month to 12 months diagnosed with congenital cystic lung disease who are scheduled for thoracoscopic lung lesion resection.
Not a fit: Patients with a history of allergy to amide local anesthetics, combined congenital heart disease, or skin issues at the puncture site may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve postoperative pain management and sleep quality in infants, leading to better recovery outcomes.
How similar studies have performed: While traditional pain management techniques have been used, the erector spinae plane block is a relatively novel approach in this context, and its effectiveness in infants has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) status I-II * age 1 month - 12 mouths old * preoperative diagnosis was congenital cystic lung disease * thoracoscopic lung lesion resection(lung lobectomy or segmentectomy) Exclusion Criteria: * patient with a history of allergy to amide local anesthetics * family members refused to participate in the study. * combined congenital heart disease * patient with skin damage or infection at the proposed puncture site * patients with scoliosis
Where this trial is running
Xi'an, Shanxi
- Second Affiliated Hospital of Xi 'an Jiaotong University — Xi'an, Shanxi, China (Recruiting)
Study contacts
- Study coordinator: Xiaoming Lei, chief physician
- Email: leixiaoming007@163.com
- Phone: +8613571903125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.